House of Representatives
State of Utah
Mr. Speaker:
The Health and Human Services Committee reports a favorable recommendation on H.B. 361,
ANTI-SEIZURE DRUG NOTIFICATION, by Representative E. Hutchings, with the following
amendments:
Paul Ray
Voting: 6-0-2
1. Page
3, Lines 80 through 89
:
80
(7) (a) For purposes of Subsection (7)
(b)
}
, "substitutes" means to substitute:
81
(i) a generic drug for another generic drug;
82
(ii) a generic drug for a nongeneric drug;
83
(iii) a nongeneric drug for another nongeneric drug; or
84
(iv) a nongeneric drug for a generic drug.
85
(b)
(c)
(c)
}
(d)
, a pharmacist or
pharmacy intern who
cannot dispense the prescribed drug as written, and who needs
to substitute
86
substitutes
}
a drug product equivalent for
{
an epilepsy
}
the
drug
prescribed to
{
a
}
the
patient to treat or
87
prevent seizures shall notify the prescribing practitioner prior to the substitution.
88
(c)
}
(d)
Notification under Subsection (7)
{
(b)
}
(c)
is not
required if the drug product equivalent is
89
paid for in whole or in part by Medicaid.
Respectfully,
Committee Chair
3 HB0361.HC1.wpd 2/15/08 10:29 am markandrews/MDA CJD/MDA
Bill Number
*HB0361*
HB0361